Sonny Hsiao is the founder of Acepodia. Acepodia has raised $259M in total funding. Latest round: Series D. Based in Alameda, California.
Sonny Hsiao is the chief executive officer at Acepodia, a clinical-stage biotechnology company focused on developing first-in-class cell therapies for cancer care. The company utilizes its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms. Acepodia has raised a total of $259 million in venture capital financing across multiple rounds, including a $100 million Series D led by Digital Mobile Venture.
Full founder directory · Investor directory · Company funding database · Fundraising library